Treatment-Related Mortality and Relapse Rate from Time of Initiation of Post-Remission Therapy for Patients Receiving Allogeneic Transplantation, Autologous Transplantation or Intensive Chemotherapy: A Report from the Eastern Cooperative Oncology Group (ECOG)

被引：0
|
作者：
Rowe, Jacob M. [1 ]
Sun, Zhuoxin [2 ]
Cassileth, Peter A. [3 ]
Appelbaum, Frederick R. [4 ]
Wiernik, Peter H. [5 ]
Lazarus, Hillard M. [6 ]
Blume, Karl G. [7 ]
Fernandez, Hugo F. [8 ]
Litzow, Mark R. [9 ]
Tallman, Martin S. [10 ]
机构：
[1] Technion Israel Inst Technol, Haifa, Israel
[2] Dana Farber Canc Inst, Boston, MA USA
[3] Univ Miami, Sylvester Canc Ctr, Miami, FL USA
[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Sch Med, Seattle, WA 98195 USA
[5] New York Med Coll, Our Lady Mercy Canc Ctr, Bronx, NY USA
[6] Univ Hosp Cleveland, Ireland Canc Ctr, Cleveland, OH 44106 USA
[7] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[8] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[9] Mayo Clin, Rochester, MN USA
[10] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 10 条
  • [1] RECOMMENDED GUIDELINES FOR THE MANAGEMENT OF AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG)
    ROWE, JM
    CIOBANU, N
    ASCENSAO, J
    STADTMAUER, EA
    WEINER, RS
    SCHENKEIN, DP
    MCGLAVE, P
    LAZARUS, HM
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 120 (02) : 143 - 158
  • [2] Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients
    Baron, Frederic
    Efficace, Fabio
    Cannella, Laura
    Willemze, Roel
    Vignetti, Marco
    Muus, Petra
    Marie, Jean-Pierre
    Ferrero, Dario
    Fazi, Paola
    La Sala, Edoardo
    Bourhis, Jean-Henri
    Fabbiano, Francesco
    Bosi, Alberto
    Sborgia, Marco
    Martinelli, Giovanni
    Wittnebel, Sebastian
    Trisolini, Silvia
    Petti, Maria Concetta
    Halkes, Constantijn J. M.
    van der Velden, Walter J. F. M.
    de Witte, Theo
    Amadori, Sergio
    Zittoun, Robert A.
    Suciu, Stefan
    [J]. HAEMATOLOGICA, 2020, 105 (01) : E13 - E16
  • [3] The Superiority of Allogeneic Hematopoietic Stem Cell Transplantation From Unrelated Donor Over Chemotherapy As Post-Remission Treatment for Patients with High-Risk Acute Lymphoblastic Leukemia in First Remission
    Hu, Jiong
    Dou, Han-Bo
    Wang, Ling
    Tang, Wei
    [J]. BLOOD, 2012, 120 (21)
  • [4] Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial
    Ribera, Josep-Maria
    Oriol, Albert
    Bethencourt, Concepcion
    Parody, Ricardo
    Hernandez-Rivas, Jesus-Maria
    Moreno, Maria-Jose
    del Potro, Eloy
    Tormo, Mar
    Rivas, Concepcion
    Besalduch, Joan
    Sanz, Miguel-Angel
    Ortega, Juan-Jose
    Feliu, E.
    Queipo de Llano, M. J.
    Fernandez-Abellan, P.
    Terol, M. J.
    Besalduch, J.
    Novo, A.
    Moscardo, F.
    Arias, J.
    Moraleda, J. M.
    Heras, I
    Bueno, J.
    Fernandez-Calvo, J.
    Borrego, D.
    Martin-Reina, V
    Deben, G.
    Carbonell, F.
    Orts, M.
    Vivancos, P.
    Grande, C.
    Bello, Jl
    Queizan, J. A.
    Guinea, J.
    Brunet, S.
    Bergua, J. L.
    Rodriguez-Villa, A.
    Atutxa, K.
    Diaz-Morfa, G.
    Hernandez-Nieto, L.
    Gamez, F.
    Llorente, A.
    Ortega-Rivas, F.
    Penarrubia, M. D.
    Poderos, C.
    Marti, J. M.
    Gardella, S.
    [J]. HAEMATOLOGICA, 2005, 90 (10) : 1346 - 1356
  • [5] Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study
    Baron, Frederic
    Efficace, Fabio
    Cannella, Laura
    Mandelli, Franco
    Willemze, Roelof
    Muus, Petra
    Marie, Jean-Pierre
    Ferrero, Dario
    Dictus, Marlies
    Fazi, Paola
    La Sala, Edoardo
    Bourhis, Jean-Henri
    Fabbiano, Francesco
    Bosi, Alberto
    Sborgia, Marco
    Martinelli, Giovanni
    Bron, Dominique
    Petti, Maria C.
    Halkes, Constantijn J. M.
    van der Velden, Walter J. F. M.
    Boccadoro, Mario
    Amadori, Sergio
    Zittoun, Robert A.
    Suciu, Stefan
    [J]. BLOOD, 2016, 128 (22)
  • [6] Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia.: Final results of the PETHEMA ALL-93 Trial
    Ribera, JM
    Oriol, A
    Bethencourt, C
    Parody, R
    Hernández-Rivas, JM
    Besalduch, J
    Sanz, MA
    Arias, J
    Fernández-Calvo, J
    Moraleda, JM
    Bueno, J
    Feliu, E
    Ortega, JJ
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S14 - S14
  • [7] Allogenic transplantation for lymphoma produces a lower relapse rate than autologous transplantation but survival is worse because of higher treatment related mortality - A report of 764 cases from the EBMT lymphoma registry.
    Peniket, AJ
    deElvira, MCR
    Taghipour, G
    deWitte, T
    Tazelaar, PJ
    Carella, A
    Vernant, JP
    Schaefer, UW
    Cleeven, M
    Boogaerts, MA
    Gluckman, E
    Goldstone, AH
    [J]. BLOOD, 1997, 90 (10) : 1121 - 1121
  • [8] Comparison of intensive chemotherapy (CHT), allogeneic (ALLO) or autologous (AUTO) stem cell transplantation (SCT) as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia (HR-ALL). Final results of the PETHEMA ALL-93 trial.
    Ribera, JM
    Oriol, A
    Bethencourt, C
    Parody, R
    Hernandez-Rivas, JM
    Moreno, MJ
    Del Potro, E
    Tormo, M
    Rivas, C
    Besalduch, J
    Sanz, MA
    Arias, J
    Fernandez-Calvo, J
    Moraleda, JM
    Bueno, J
    Feliu, E
    Ortega, JJ
    [J]. BLOOD, 2004, 104 (11) : 746A - 747A
  • [9] Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute Lymphoblastic Leukemia (ALL) Receiving Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in First Complete Remission: Results From the GMALL Study Group
    Stelljes, Matrhias
    David, Mareike
    Arnold, Renate
    Beelen, Dietrich W.
    Bethge, Wolfgang A.
    Bornhaeuser, Martin
    Dengler, Jolanta
    Finke, Juergen
    Kolb, Hans J.
    Kolbe, Karin
    Kroeger, Nicolaus
    Niederwieser, Dietger
    Roesler, Wolf
    Schwerdtfeger, Rainer
    Kienast, Joachim
    Goekbuget, Nicola
    Hoelzer, Dieter
    [J]. BLOOD, 2009, 114 (22) : 1301 - 1301
  • [10] Declining Rates of Treatment-Related Mortality in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Given "Intensive" Induction Regimens: A Report From the Southwest Oncology Group (SWOG) and MD Anderson Cancer Center (MDA)
    Othus, Megan
    Kantarjian, Hagop M.
    Petersdorf, Stephen
    Ravandi, Farhad
    Cortes, Jorge E.
    Pierce, Sherry A.
    Erba, Harry Paul
    Faderl, Stefan
    Appelbaum, Frederick R.
    Estey, Elihu H.
    [J]. BLOOD, 2012, 120 (21)
1